Islet transplantation is a promising therapy for T1DM. Key factors influencing islet yield have been identified with conflicting results. In this study, we analyzed 276 isolations to identify variables for islet yield and, additionally, islet size and size distribution. Pearson correlation analyses demonstrated that BMI had a positive correlation with pancreas size, actual islet count (AIC), and islet equivalent (IEQ)/g (all p £ 0.009), while CIT had a negative correlation with AIC and IEQ/g (all p £ 0.003). In mixed linear regression, BMI also had a positive correlation with islet size but only for shorter digestion times (£15 min); there was no association between BMI and islet size for longer digestion times (>15 min). CIT was not associated with islet size. Donor age, sex, and preservation solutions were shown to have no correlation with islet yields or size distribution. Pancreas size had a positive correlation with AIC and a negative association with IEQ/g; it also had positive association with islet size but only for females, not males. Overdigestion was positively associated with islet counts; however, there was also a greater proportion of smaller islets when digestion rate was >74% (p = 0.005). Of the three collagenases analyzed, Sigma V had the lowest digestion rate (mean = 65%), approximately 5% or 10% lower than Roche Liberase HI (p = 0.04) and Serva NB1 (p = 0.0003), respectively; however, the Sigma V group showed better islet size preservation. Yet, the enzymes resulted in similar IEQ/g digested tissue. Of the isolated islets, 70.2% were smaller than 150 µm and contributed only 20.4% to the total IEQ, while 7.4% of the islets were larger than 250 µm but contributed 42.4% to the total IEQ. In summary, BMI, pancreas size, and CIT are useful variables for predicting islet yield, but selection of enzyme and balancing digestion time and rate are also important.
INTRODUCTION
Islet transplantation has become a promising alternative therapy for type 1 diabetes mellitus since the introduction of the Edmonton protocol in 2000 (22) . Two key findings were introduced with the Edmonton protocol: first, islet mass is an important factor for the success of islet transplantation in that a total of ~12,000 islet equivalents (IEQ)/kg recipient body weight is required to achieve insulin independence, and second, the Edmonton protocol demonstrated success of a steroid-free immunorepression regimen for human islet transplantation. Researchers continue to improve upon the Edmonton protocol; however, there are still inconsistent short-and long-term success rates between centers. Therefore, in order to attain widespread clinical application, current organ preservation and isolation techniques need to be improved to consistently achieve the necessary high islet quality and quantity. In addition, careful selection of immunosuppressive regimen with limited b-cell toxicity and the discovery of new transplant sites with a better microenvironment for achieving long-term islet grafting and survival are important.
Pancreatic islets of Langerhans are a well-defined three-dimensional cluster, consisting of 1,500-2,000 cells, with an average diameter of 150 µm (range of 50-500 µm). A healthy adult human pancreas contains approximately 1 million islets, with a total islet mass equal to 1-2% of the total pancreas weight. In vitro, islet yields are measured as either actual islet count (AIC) or IEQ, a volumetric quantification of islet mass. An islet with a diameter of 150 µm is considered the standard to convert islet mass into IEQ (19) . Therefore, a larger islet contributes to the IEQ more than a smaller islet. The overall mass of the isolated islet population and the size distribution of the individual islets are mainly influenced by three categories of factors: donor factors [age, sex, and body mass index (BMI)], preisolation and isolation factors [quality of the pancreas flush and preservation, cold ischemia time (CIT), pancreas size, enzyme used for digestion, digestion time and rate, purification medium, and protocol], and postisolation factors (culture medium type, temperature, and length).
Clinical studies have produced inconsistent results regarding whether transplanted IEQ is correlated with the probability of attaining insulin independence (8, 10) . The inaccuracy of manual quantification of islet mass, with its subjectivity and potential for error, may be one reason for the inconsistent results. Vigorous efforts have been made to overcome the disadvantage of the standard manual evaluation of islet mass (4, 9, 11, 16) through the use of computer-or digital-assisted approaches. However, no accurate method currently exists.
Recent evidence also suggests that small islets are superior for human islet transplantation. This has been observed clinically in that patients that received smaller islets needed fewer islets to achieve the same C-peptide production as patients who received a greater number of larger islets (10). Similar results have also been demonstrated in a rodent model by Macgregor et al. In these studies, all animals failed to achieve normoglycemia when larger islets were transplanted in a minimal mass model, whereas 80% of the animals reversed diabetes when smaller islets were transplanted in the same model (12). In addition, glucosestimulated insulin secretions of smaller rodent and human islets in vitro are superior to larger islets (5, 14) .
In spite of the emerging evidence demonstrating that islet size may play an important role in transplant outcomes in addition to islet mass, factors that potentially impact islet size and size distribution in islet preparations have not been systematically analyzed. In the current study, we retrospectively examined a large sample of human islet isolation preparations performed at the University of Illinois at Chicago (UIC) with the aim to determine whether donor and isolation factors influence islet size. Our results may help improve pancreas preservation and islet isolation techniques with the goal of achieving a more consistent islet product for transplantation.
MATERIALS AND METHODS

Pancreas Procurement and Isolation Activities
The pancreata were provided by organ procurement organizations (OPO) with consent from donors. The organs were cold flushed with either University of Wisconsin (UW; DuPont Pharma, Mississauga, ON, Canada) or histidine-tryptophan-ketoglutarate (HTK; Essential Pharma, Newtown, PA, USA) solution, depending upon the protocol used by the individual OPO, and stored at 4°C before transport to UIC for islet isolation. The pancreatic islets were isolated according to previously described procedures (6, 19, 22) . In brief, pancreata weights were quantified after the initial surface decontamination and excess fat trimming. One of three different types of collagenase [Roche Liberase HI (Roche, Indianapolis, IN, USA), Serva NB1 (Serva Electrophoresis, Heidelberg, germany), and Sigma V (Sigma-Aldrich, St. Louis, MO, USA)] was then infused into the pancreata via the pancreatic duct. The inflated pancreata were then cut into 10-12 pieces and placed in a Ricordi chamber (Biorep Technologies, Miami, FL, USA) with a close-loop circulation system equipped with a heating controller, tissue sampling port, and tissue collection outlet (20). The pancreatic tissue digestion and islet dissociation were maintained at 35-37°C, and digestion efficacy was determined by microscopic observation of islet cleavage (degree of islets released from exocrine tissue) and tissue volume. The dilution phase started when the digestion was stopped and maintained for an additional 30-60 min.
After the dilution phase, the digested tissue was washed to remove traces of enzyme and incubated in UW solution on ice for 30 min. A refined UIC-UW/Biocoll (UIC-UB) continuous density gradient (1), consisting of a mixture of a high-density solution [1.078 g/ml: 40% Biocoll (Cedarlane, Burlington, ON, Canada) and 51% UW] and a low-density solution (1.068 g/ml: 30% Biocoll and 70% UW), was used for the separation of islets from exocrine tissues in a COBE 2991 Cell Separator (CARIDIAN BCT, Lakewood, CO, USA). Following the centrifugation process, the separated tissues were collected in 12 fractions. The first two fractions were discarded because the tissue volume is minimal (often less than 0.01 ml) and consists mostly of ductal and adipose cells. For the remaining 10 fractions, corresponding to the aforementioned continuous gradient from 1.068 to 1.078 g/ml, 30 ml of fluid volume was collected in each fraction, and then the fractions were recombined based on the percentage of islet purity.
Assessment of Islet Yields in AIC and IEQ
Final islet yields were measured both in AIC and IEQ according to previously described methods (17). In brief, 30 µl of 1% dithizone (DTZ; Sigma-Aldrich) solution was added into 1.0 ml of islet sample (250´ dilution factor) for 1-2 min at room temperature to stain for zinc. Red DTZ-stained islets were counted using a reticle (Thermo Scientific, Rochester, NY, USA) certified to a correction factor of 0.98 to 1.02 in the eyepiece of a light microscope (Leica MZ95; Leica Microsystems, Buffalo grove, IL, USA) at 40´. The distance across the two spaces on the calibrated reticle in the eyepiece equals 50 µm. The islets smaller than 50 µm were not counted since their contribution to IEQ was not substantial. Total AIC were then calculated by multiplying by a dilution factor of 250. Eight discrete categories were designated for islet size quantification: 50-100, 100-150, 150-200, 200-250, 250-300, 300-350, 350-400 , and >400 µm. By multiplying AIC in each size category by an IEQ conversion factor (0.167, 0.648, 1.685, 3.500, 6.315, 10.352, 15.833, and 32.500, respectively) and summing, the total IEQ was then determined.
Data Analysis Criteria
Any isolation needing more than one purification process was excluded from this analysis because a prolonged exposure of islets to UW from a second or third purification may cause changes in islet size. There were 276 human islet isolations with complete data, which were therefore appropriate for the analysis.
Stastistical Analysis
Statistical analyses were conducted using SAS, version 9.2 (Cary, NC, USA), and R Project for Statistical Computing, version 2.13.1 (http://www.R-project.org). Statistical significance was set at p < 0.01 to minimize type 1 error from the multiple comparisons. Data were checked for normality and log transformed when necessary (e.g., AIC, IEQ/g pancreas).
Sample characteristics are presented as means ± standard deviations (SD), medians, or frequencies. Pearson correlations were calculated to determine associations between donor and isolation characteristics and islet yields to utilize the data as continuous variables; biserial correlations were calculated when a binary variable (sex, preservation solution) was one of the variables. The magnitude of the coefficients was categorized as no correlation (0-0.1), small correlation (0.1-0.3), medium correlation (0.3-0.6), large correlation (0.6-0.8), and measuring the same characteristic (0.8-1.0).
Associations of collagenase with donor and isolation characteristics and islet yields were determined using the overall F tests and t tests from regression models with collagenase as a dummy variable and Sigma as the reference group for continuous variables and chi-square tests for categorical variables. Frequencies and cumulative frequencies of AIC and IEQ were also determined across eight islet size categories.
Donor and isolation characteristics were then stratified into two categories (median splits for age, BMI, pancreas size, CIT, digestion time or digestion rate; sex or preservation solution). Multivariable mixed linear regression models were used to determine whether the AIC distributions across islet size categories differed between the two levels of these characteristics (e.g., sex or BMI categories). These mixed models incorporated the correlation due to clustering by specifying the unique isolation identification number as the unit of cluster and specified the autoregressive covariance structure with empirical standard errors. AIC frequencies within each of the eight islet size categories were compared between the three collagenase types using t tests from mixed regression models with collagenase as a dummy variable and the Sigma as the reference group.
Modification of the effect of donor and isolation characteristics on islet size distribution was determined by testing for interactions between the characteristics (median splits for age, BMI, pancreas size, CIT, digestion time or digestion rate; sex, preservation solution, or collagenase); those variables found to significantly modify the effect of donor and isolation characteristics are presented. Whether differences by collagenase were confounded by other donor or isolation characteristics was tested by entering each characteristic individually into each mixed model and noting any substantial change in the regression coefficients; no variables were found to confound the effect of collagenase.
RESULTS
General Characteristics
Donor and isolation characteristics and outcomes of 276 isolations are listed in Table 1 ; results are comparable to other published studies. Of particular note, Roche Liberase HI was the most common collagenase used in the current study, as it was the most widely used enzyme until it was discontinued in 2007. Mean ± SD AIC was 297,891 ± 178,313 (median 257,816). Mean ± SD IEQ/g digested tissue was 2,943 ± 1,702 (median 2,684). Figure 1a and b shows the average size distribution of human islets expressed as AIC and IEQ. In our isolated human islet preparations, 70.2% of the AICs was less than 150 µm (the average human islet size in situ) but contributed only 20.4% to the total IEQ, while 7.4% of the islets were larger than 250 µm but contributed 42.4% to the total IEQ.
Islet Size Distribution and Contribution to IEQ
Correlation Analysis of Key Donor and Isolation Factors and Islet Yields
Pearson correlations are shown in Table 2 . Donor age was negatively correlated with the digestion rate (r = −0.16, p = 0.006), indicating that older donor age was associated with a lower pancreas digestion rate. Male donors had a significantly larger pancreas size than females (p < 0.0001). Donor BMI positively correlated with pancreas size, AIC, and IEQ/g (all p £ 0.009). Donor pancreas size had a positive correlation with AIC (r = 0.20, p = 0.001) but had a negative correlation with IEQ/g (r = -0.25, p < 0.0001), indicating that a larger pancreas size yields greater AIC with a smaller IEQ/g. No characteristics were associated with preservation solution.
CIT was negatively correlated with digestion time, AIC, and IEQ/g (all p £ 0.003). These results suggest that a longer ischemia time is associated with shorter digestion time and smaller islet yields. Digestion time had a negative correlation with AIC and IEQ/g (p = 0.0004 and p < 0.0001, respectively). However, pancreatic digestion rate had a positive correlation with both AIC and IEQ/g (p = 0.009 and 0.004, respectively). AIC was strongly correlated with IEQ/g (r = 0.90, p < 0.0001).
Impact of Preisolation and Isolation Factors on Islet Size Distribution
The islet size distribution across eight islet size groups were compared between two strata of key preisolation and isolation factors (Figs. 2 and 3, respectively). None of the preisolation factors (age, sex, BMI, preservation solution, and CIT) altered the overall islet size distribution (p = 0.03-0.94). The isolation factors, pancreas size (p = 0.10) and digestion time (p = 0.64), also did not impact the overall islet size distribution. However, a greater digestion rate (>74%) yielded a greater proportion of islets <100 µm and a smaller proportion of islets >100 µm when compared with lower digestion rates (£74%; p = 0.005), indicating a shift toward smaller islets when digestion rates are higher.
When effect modification was explored, donor BMI had a significant positive association with islet size when digestion times were shorter (£15 min; p = 0.0009), whereas BMI was not associated with islet size when digestion times were longer (>15 min; p = 0.97) ( Fig. 4a  and b) . A pancreas size >100 g had significantly larger islets than a pancreas size of £100 g, but only for females (p = 0.008) and not males (p = 0.75) ( Fig. 4c and d) .
Impact of Collagenase Used in Digestion Phase on Islet Size Distribution
Donor and isolation characteristics and islet yields were compared among the three enzymes used in Table 3 . Donor age, sex, BMI, and preservation solution were not found to significantly differ between the three collagenase groups. Collagenase used was associated with the following variables: pancreas size (Roche Liberase HI: 112.3 ± 30.1 g, Serva NB1: 95.1 ± 29.3 g, and Sigma V: 94.6 ± 28.2 g; overall F test, p < 0.0001), cold ischemia time (Roche Liberase HI: 8.8 ± 2.5 h, Serva NB1: 9.3 ± 2.9 h, and Sigma V: 10.7 ± 2.5 h; overall F test, p < 0.0001), digestion time (Roche Liberase HI: 17.6 ± 5.2 min, Serva NB1: 14.4 ± 4.5 min, and Sigma V: 15.2 ± 2.6 min; overall F test, p < 0.0001), digestion rate (Roche Liberase HI: 70.3 ± 15.3 %, Serva NB1: 75.8 ± 13.0 %, and Sigma V: 65.0 ± 17.5 %; overall F test, p = 0.001), AIC (log) (Roche Liberase HI: 12.5 ± 0.6, Serva NB1: 12.2 ± 0.7, and Sigma V: 12.3 ± 0.6; overall F test, p = 0.0002). However, there was no significant difference of IEQ/g pancreas among the three groups.
We further analyzed the impact of the three enzymes on the AIC frequencies within the eight islet size categories (Fig. 5 ). The Sigma V had a significantly higher AIC frequency in the 100-150-and 150-200-µm size groups and a significantly lower AIC frequency in the 50-100-µm size group. There were no significant differences in AIC frequencies among the three enzymes for the size groups larger than 200 µm. Adjusting the models for digestion rate or pancreas size did not substantially change the differences between collagenase in the three smallest islet size groups.
DISCUSSION
One of the limiting factors to the widespread application of islet transplantation is the need for a large number of islets from one or multiple pancreata per recipient. Previous studies have demonstrated that a number of key determining factors are associated with islet yield (3, 13, 15, 18) , such as donor age, BMI, pancreas size, pancreatic quality, enzymes, and digestion duration. These are often considered during organ screening prior to islet isolation and are used as predictors of isolation success. However, these studies only analyzed the impact on overall islet yield in terms of AIC, IEQ, or AIC/IEQ. To the best of our knowledge, no analysis has been conducted to determine the impact of these factors on islet size and size distribution across discrete size categories.
Theoretically, all the aforementioned preisolation and isolation factors could influence islet yield and size distribution in a given islet preparation. However, human islet isolations consist of multiple harsh physical and chemical processes, such as long ischemia times, enzymatic digestion and dissociation, and islet purification. Therefore, the contribution of each factor to islet yield and size could be unchanged, increased, or decreased during each step of the isolation process.
Our analysis of 276 isolations showed that, on average, 70.2% of AICs are smaller than a standard IEQ (less than 150 µm) and contribute to only 20.4% of the total IEQ, and larger islets (>250 µm) make up only 7.4% of the AIC but contribute to 42.4% of the total IEQ ( Fig. 1a and b). This indicates that a significant amount of islets are fragmented or damaged during the isolation process, and preserving islet size during the isolation process is very important in improving islet yield.
Our results also demonstrated that donor age did not have any significant association with either AIC, IEQ/g (Table 2 ), or islet size (Fig. 2a) . Male donors were found to have a larger pancreas size than female donors; however, donor sex had no significant correlation with AIC, IEQ/g, or islet size distribution (Table 2 and Fig. 2b ), suggesting that any influence of donor sex on final islet yield is not decisive and is probably outweighed by other factors, such as BMI. However, sex did modify the effect of pancreas size on islet size. In male donors, there was no significant impact of pancreas size on islet size distribution, whereas in female donors, a larger pancreas (>100 g) had a greater proportion of larger islet sizes compared with a smaller pancreas (£100 g) ( Fig. 4c and d) . The underlying mechanism associated with this sex difference is unknown but may be related to the well-known increase in islet mass and b-cell proliferation during pregnancy in response to the higher insulin demands from weight gain, fetal burden, and placental hormone production. Unfortunately, data on donor history of pregnancy are not available. (c and d) AIC frequencies stratified by donor pancreas size of >100 g and £100 g for females and males. A value of p < 0.01 is considered statistically significant for comparison of AIC distributions across islet size categories between the two groups.
The quality of the pancreas preservation is a critical factor associated with islet isolation success, and so the solutions used for pancreas flush and storage have drawn much attention. UW has been considered the gold standard for pancreata intended for islet isolation. In this analysis, HTK and UW solutions had similar digestion times, digestion rates, AIC, and IEQ/g (Table 2 ) and no difference in islet size and size distribution (Fig. 2d) . These results are consistent with our previous study (21) .
As previously demonstrated, prolonged cold ischemia time is detrimental to islet yield. In this study, we also found that CIT had a significant negative correlation with AIC and IEQ/g, as well as digestion time (Table 2) . However, the impact of CIT on islet size distribution was minimal ( Fig. 2e ). Both results suggest that the impact of ischemia-associated islet cell injury is more pronounced on islet yield than islet size distribution.
Donor BMI had a significant positive correlation with pancreas size, AIC, and IEQ/g (Table 2) , which is consistent with other studies (2,7). It has been suggested previously that increased fat infiltration in the pancreas may facilitate islet release during the collagenase digestion, and the higher digestion rate contributes to islet yield (2). However, this analysis showed that donor BMI had no correlation with either digestion time or digestion rate ( Table 2) , indicating that the positive correlations of donor BMI with AIC and IEQ/g are more likely a function of the greater number of islets in pancreata from individuals with higher BMI. This is indirectly supported by Figure 2c , which shows that the overall size distribution did not differ between groups stratified by BMI.
Since digestion time is strongly associated with efficacy of islet release from acinar tissue and digestion rate, finding the appropriate balance between the pancreas digestion time and digestion rate, which has been found to be operator dependent, is essential to the human islet isolation process. Our results demonstrated that digestion time was not associated with digestion rate (Table 2) . However, digestion time had a significant negative correlation with AIC and IEQ/g, while digestion rate had a positive correlation with AIC and IEQ/g. Digestion time did not have a significant impact on overall islet size Figure 5 . AIC frequencies within eight islet size groups stratified by the collagenase used. n = 276. A value of p < 0.01 is considered statistically significant, with Sigma as the reference group. (Fig. 3b ), but it did modify the impact of BMI on islet size. Our results indicated that BMI was positively associated with islet size when digestion time was kept at £15 min, whereas for digestion times >15 min (an indication of overdigestion), the impact of BMI on islet size was diminished ( Fig. 4a and b) . In comparison, a higher digestion rate (>74%) yielded a greater percentage of small islets than a lower digestion rate (£74%) (Fig. 3c) , indicating that pancreatic overdigestion can fragment islets.
In a previous study, it was found that the average in situ insulin-positive cross-sectional area, a measure of islet size prior to digestion, had no correlation with the proportion of small islets of given isolated islet products but had a correlation with collagenase used for tissue digestion, suggesting that the yields comprised of small islets are a direct result of the isolation itself (7). In addition, since digestion time and rate are primarily influenced by the collagenase used in the digestion phase, we further compared the three different collagenases utilized in our isolations. Sigma V had the lowest digestion rate, 5-10% less than both Roche Liberase HI and Serva NB1, while Roche Liberase HI had the longest digestion time and highest AIC. However, all three enzymes had similar IEQ/g (Table 3 ). Sigma V preserved islet size better than Roche Liberase HI and Serva NB1, showing a significantly higher number of islets in the larger-sized groups (Fig. 4) . Together, these data indicate that Sigma V has an effect equal to that of purified enzymes on islet yield but more efficiently releases islets from pancreatic tissue, while better preserving islet size. This is consistent with our previous study showing that the Sigma V has similar human islet isolation and clinical outcomes compared to highly purified enzymes, such as Serva NB1, with little lot-to-lot variation (23).
There are several conclusions derived from this study worth emphasizing. First, donor BMI is an important factor for determining isolation success, with a significant positive association with islet yield (AIC and IEQ/g). In addition, higher BMI donors are beneficial for yielding bigger-sized islets when digestion progress is closely monitored. Second, it is important to reduce cold ischemia time and prevent ischemia-reperfusion-associated islet cell injury. It has been shown that UW and HTK have comparable efficacy for preserving pancreata intended for islet isolation; however, for organs with prolonged ischemia time, the efficacy of both solutions is diminished. While both solutions show similar effectiveness, it is necessary to find alternatives or to improve these existing preservation methods to enhance islet function. Last, a systematic analysis of the essential components of collagenase is necessary to ultimately deliver a well-defined enzyme blend that can provide a reliable and consistent islet product. This is particularly significant in the case of research pancreata, where the implementation of a low-cost collagenase would increase the amount of isolations performed for the purpose of research.
There are limitations to this study, mainly the imprecise assessment techniques that are commonly employed during the islet isolation procedure. Subjectivity is inherent in the established methods for islet yield and size. However, we believe that variation due to user error and subjectivity did not substantially affect this analysis because all isolations were performed by experienced isolation technicians, according to a standardized islet isolation protocol. A second limitation is that postdigestion islet size and size distribution were not included. It would be ideal to analyze islet size distribution in both the postdigestion and postpurification products, as the islet purification process can potentially change islet size through cellular edema and purification media toxicity. We believe that, due to the impurity (1-2%) of the postdigestion sample, it is prone to islet counting errors and sampling bias; therefore, it was not included in the analysis.
To our knowledge, this is the first analysis of factors that impact islet size distribution in addition to islet yield. We used regression modeling and found that BMI, pancreas size, and CIT are useful variables for predicting islet yield, but selection of enzyme and balancing digestion time and digestion rate are also important for isolation success.
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